Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart failure drug combo: is starting both at once safe?

NCT ID NCT05989503

First seen Nov 19, 2025 · Last updated May 01, 2026 · Updated 22 times

Summary

This study looked at 62 adults with heart failure and reduced pumping ability. Researchers compared starting two medications (sacubitril/valsartan and an SGLT2 inhibitor) at the same time versus starting one drug first and adding the other later. The goal was to see which approach is safer over 6 months by tracking side effects like low blood pressure, kidney problems, and hospital visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centro Hospitalar Universitário São João

    Porto, 4200-319, Portugal

  • Centro Hospitalar Universitário de Santo António

    Porto, Porto District, 4099-001, Portugal

  • Centro Hospitalar Vila Nova de Gaia/Espinho

    Porto, 4434-502, Portugal

  • Faculty of Medicine (FMUP)

    Porto, 4200-319, Portugal

  • Unidade Local de Saúde de Matosinhos - Hospital Pedro Hispano

    Porto, Portugal

Conditions

Explore the condition pages connected to this study.